While the vast majority of Ph+ ALL patients express either the common e1a2, or less frequent e13a2 or e14a2 BCR-ABL1 fusion transcripts (Figure 1(Fig. 1)), a minority harbor variants, usually as a consequence of alternative splicing of either BCR or ABL1 exons. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.